Navigation Links
Medarex Announces 2007 Fourth Quarter and Year End Financial Results
Date:2/26/2008

cluding the items discuss below. Medarex's management believes investors' understanding of Medarex's financial performance is enhanced as a result of our disclosing these non-GAAP financial measures. Non-GAAP net loss and non- GAAP net loss per share should not be viewed in isolation or as a substitute for GAAP net loss or GAAP net loss per share.

MEDAREX, INC.

Reconciliation of GAAP Net Loss to Non-GAAP Net Loss

(In thousands, except per share data)

(unaudited)

Year Ended Three Months Ended

December 31, December 31,

(unaudited) (unaudited)

2007 2006 2007 2006

GAAP Net loss $(27,067) $(181,701) $(44,823) $(57,705)

Celldex Net loss (1) 15,231 17,227 3,876 5,276

Minority interest -

Celldex (1) (4,699) (6,891) (157) (2,110)

Stock-based compensation

expense (2) 18,551 19,177 4,775 7,121

Acquisition of in-process

technology related

to Ability Biomedical 6,900 - - -

Impairment loss on

investments in partners 2,141 5,170 - 5,170

Non-cash gain on loss

of significant influence

in Genmab - (3,202) - -

Gain on sale of Genmab

stock (152,143) - - -

Non-GAAP Net loss $(141,086) $(150,220) $(36,329) $(42,248)

GAAP Net loss per share,

basic and diluted $(0.21) $(1.50) $(0.35) $(0.46)

Non-GAAP Net loss

per
'/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Medarex to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
2. Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis
3. PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM)
4. Medarex to Present at the JPMorgan Small/Mid Cap Conference
5. Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody
6. Grupo Casa Saba Announces Fourth Quarter 2007 Results
7. Lixte Biotechnology Holdings, Inc. Announces Further Developments Regarding the Anti-Cancer Activity of Its Patent-Pending Proprietary Compounds
8. Reproductive Medicine Associates of Texas Announces Open House in San Antonio
9. WallSt.net (www.WallSt.net) Announces Upcoming Interview With Chairman and CEO of flexSCAN, Inc.
10. Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment
11. Thomson Healthcare Announces Enhancements to Order Sets Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... TUESDAY, Sept. 23, 2014 (HealthDay News) -- ... (ADHD) also undergo behavioral therapy, and the rates ... a new study finds. Medication alone can ... some do better if they also receive behavioral ... The researchers analyzed data in more than 1,500 ...
(Date:9/23/2014)... obese as teenagers could grow up to earn up ... weight. So says Petter Lundborg of Lund University, Paul ... University and Lund University, all in Sweden. The team ... the United States, and the results are published in ... analyzed large-scale data of 145,193 Swedish-born brothers who enlisted ...
(Date:9/23/2014)... Vancouver Electrician Contractors, Pro Ace, has ... electrical services in Vancouver, BC. The company will provide ... a small maintenance project or a large-scale new installation ... meet the needs of the individual commercial client. Pro ... of an affordable price. As a result, businesses of ...
(Date:9/23/2014)... The Sloane Clinic™, a leading chain of ... advanced aesthetic dermatology and cosmetic solutions now adds ... care repertoire. Specially formulated with super-powered antioxidant Lipo-Fullerene ... forces of aging, acne and photo damage while ... is revolutionizing the way we treat and protect ...
(Date:9/23/2014)... 23, 2014 Risperdal lawsuits ( http://www.drugbot.com/risperdal/lawsuit/ ... country, Bernstein Liebhard LLP reports. According to an Order ... on September 19th, the Court has dismissed fraud and ... that jurisdiction on behalf of a man who allegedly ... to his use of Risperdal. In dismissing the Plaintiff’s ...
Breaking Medicine News(10 mins):Health News:Kids Taking ADHD Drugs Get Little Psychotherapy: Study 2Health News:Note to young men: Fat doesn't pay 2Health News:Pro Ace Now Offers Commercial Electrical Services in Vancouver 2Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 2Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 3Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 4Health News:Risperdal Lawsuit News: Fraud, Negligence Per Se Claims Dismissed from Florida Complaint, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuit News: Fraud, Negligence Per Se Claims Dismissed from Florida Complaint, Bernstein Liebhard LLP Reports 3
... the risk of colon cancer. It is well known that ... the risk of cancer. Now researchers are beginning to find ... produce contain. //The latest report, from researchers at Hopkins University, ... risk of colon cancer. ,Groups of rats that ...
... new review of the medical proof, the drug pentoxifylline is ... ulcers are caused by poor circulation and they are quite ... by compression stretch bandages, but up to a third of ... treatment.// ,Doctors at the University of New Zealand, ...
... loss are going down well with those who use them. ... over 60 in the United States. Traditionally there was one ... hearing aid. // ,Now, however, there's another choice - ... surrounding bones. Researchers in the US have surveyed 100 adults ...
... has to be taken into consideration before deciding to ... acoustic swannoma) is a benign tumour affecting the eighth ... hearing and problems with balance.// Standard treatment is removal ... whether this is worthwhile in older people with limited ...
... a huge men population, which evaluated more than 14,000 sperm ... reducing their numbers as well as their crucial ability to ... as the ozone level went up, the sperm concentration went ... and obstetrics and gynecology at the University of Southern California's ...
... radiant-light therapy may be an effective treatment for depression ... of psychiatry at the Yale School of Medicine in ... potentially non-toxic antidepressant light therapy in pregnancy is a ... experiment to see whether exposure to bright light, a ...
Cached Medicine News:Health News:Elevated Ozone Levels Hurt Sperm Count 2
(Date:9/23/2014)... Sept. 23, 2014   MedNet Solutions , a global ... is pleased to announce that it will once again be ... (SCDM) Annual Conference, to be held this year from September ... , Nevada. MedNet team members, in conjunction with representatives from many ... will also be in attendance, will be providing demonstrations of ...
(Date:9/23/2014)... ORLANDO, Fla. and DUBLIN ... Inc. (OTC-BB: TNIB) ("we" or the "Company"), a ... innovative therapies for autoimmune diseases in emerging nations, ... has approved our common stock for DTC,s Deposit ... Fast Automated Securities Transfer Service ("FAST") transfer agent ...
(Date:9/23/2014)... Sept. 23, 2014  Hill-Rom (NYSE: HRC ... Health ( Renton, WA ), the nation,s ... the companies, existing relationship as Hill-Rom now becomes Providence ... capital bed frame and surface products. ... in the U.S.  It operates 34 hospitals, 475 physician ...
Breaking Medicine Technology:MedNet Solutions - Proud To Sponsor The SCDM 2014 Annual Conference 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 3TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 4Hill-Rom Announces Seven-Year, Sole-Source Contract with Providence Health 2
... SILVER SPRING, Md., May 2, 2011 The U.S. ... used with diet and exercise, to improve blood glucose ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) People with Type ... insulin, a hormone that regulates the amount of glucose ...
... and SEATTLE, May 2, 2011 CMC Biologics, ... in Copenhagen, Denmark and Seattle, Washington USA, announced ... serve at its Chief Executive Officer. CMC Biologics, ... delivering  world class, fully integrated, biopharmaceutical process development ...
Cached Medicine Technology:FDA Approves New Treatment for Type 2 Diabetes 2CMC Biologics Announces Appointment of New CEO 2
Standard knife with box, C profile...
... some sectioning work, it is necessary to cool ... Freezer can be fitted to most microtomes and ... or lower, depending on conditions. The equipment consists ... The cooling stage is best suited for operation ...
... Stages fit easily onto most microtomes. These ... only the AC supply and a trickle of ... immediately and can be maintained indefinitely. Stage ... can be set for different kinds of tissue. ...
ELISA kit for the quantitative determination of autoantibodies to glutamic acid decarboxylase (GAD65) in serum...
Medicine Products: